Cart
sales@molnova.com
Triflubazam
CAS No. 22365-40-8
Triflubazam( —— )
Catalog No. M36119 CAS No. 22365-40-8
Triflubazam has a wide range of biological activities that can affect sleep and can be used to treat anxiety syndromes and psychological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 120 | In Stock |
|
| 10MG | 177 | In Stock |
|
| 25MG | 334 | In Stock |
|
| 50MG | 452 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTriflubazam
-
NoteResearch use only, not for human use.
-
Brief DescriptionTriflubazam has a wide range of biological activities that can affect sleep and can be used to treat anxiety syndromes and psychological disorders.
-
DescriptionTriflubazam has a wide range of biological activities that can affect sleep and can be used to treat anxiety syndromes and psychological disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number22365-40-8
-
Formula Weight334.29
-
Molecular FormulaC17H13F3N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N(C=2C(N(C)C(=O)C1)=CC=C(C(F)(F)F)C2)C3=CC=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
4,5-Di-O-caffeoylqui...
4,5-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV.
-
alpha-Chaconine
Alpha-Chaconine has anti-inflammatory effect, associated with the suppression of AP-1, and supports its possible therapeutic role for the treatment of sepsis. Alpha-Chaconine also has cytotoxic effects.
-
6-Acryloyloxyhexyl p...
6-Acryloyloxyhexyl phosphater (PA21) is a novel phosphate-binding agent, which is an iron-based reagent, and can be used for the treatment of hyperphosphatemia in chronic kidney disease.
